![Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 | Modern Pathology Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2017.46/MediaObjects/41379_2017_Article_BFmodpathol201746_Fig4_HTML.jpg)
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 | Modern Pathology
![Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer | In Vivo Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer | In Vivo](https://iv.iiarjournals.org/content/invivo/36/4/1820/F1.large.jpg?width=800&height=600&carousel=1)
Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer | In Vivo
![Frontiers | Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining Frontiers | Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining](https://www.frontiersin.org/files/Articles/493599/fmed-06-00247-HTML/image_m/fmed-06-00247-g002.jpg)
Frontiers | Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
![3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive 3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive](https://www.snfge.org/sites/www.snfge.org/files/SNFGE/TNCD/tncd_chap-03_figure-4.png)
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
![Adam L. Booth, MD on X: "Tumor budding overview and grading Dr. Heather Dawson #cap19orl #gipath https://t.co/Jg8SDQgo9Y" / X Adam L. Booth, MD on X: "Tumor budding overview and grading Dr. Heather Dawson #cap19orl #gipath https://t.co/Jg8SDQgo9Y" / X](https://pbs.twimg.com/media/EFQSyyAWwAomtB3.jpg:large)
Adam L. Booth, MD on X: "Tumor budding overview and grading Dr. Heather Dawson #cap19orl #gipath https://t.co/Jg8SDQgo9Y" / X
![Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer - ScienceDirect Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0046817718304209-gr1.jpg)
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer - ScienceDirect
![JCM | Free Full-Text | Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes JCM | Free Full-Text | Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes](https://www.mdpi.com/jcm/jcm-13-00134/article_deploy/html/images/jcm-13-00134-g001.png)
JCM | Free Full-Text | Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes
![Deepening understanding of tumor budding in colorectal cancer for effective immunotherapy - Lunaphore Technologies Deepening understanding of tumor budding in colorectal cancer for effective immunotherapy - Lunaphore Technologies](https://lunaphore.com/wp-content/uploads/2022/12/Lunaphore-Tumor-budding-poster-figure.png)
Deepening understanding of tumor budding in colorectal cancer for effective immunotherapy - Lunaphore Technologies
![Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer | BMC Cancer | Full Text Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-022-09957-8/MediaObjects/12885_2022_9957_Fig2_HTML.png)
Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer | BMC Cancer | Full Text
![Tumor budding (an isolated single cancer cell or a cluster composed of... | Download Scientific Diagram Tumor budding (an isolated single cancer cell or a cluster composed of... | Download Scientific Diagram](https://www.researchgate.net/publication/44602457/figure/fig1/AS:272139123163203@1441894431683/Tumor-budding-an-isolated-single-cancer-cell-or-a-cluster-composed-of-fewer-than-five.png)
Tumor budding (an isolated single cancer cell or a cluster composed of... | Download Scientific Diagram
![Cancers | Free Full-Text | Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer Cancers | Free Full-Text | Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer](https://www.mdpi.com/cancers/cancers-03-02767/article_deploy/html/images/cancers-03-02767f1.png)
Cancers | Free Full-Text | Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer
![PDF] Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget | Semantic Scholar PDF] Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1ffa8053e679cccbbd98c7274eec0e13f51a702b/3-Figure2-1.png)
PDF] Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget | Semantic Scholar
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (
![Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients - ScienceDirect Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804920300563-gr1.jpg)
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients - ScienceDirect
![Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer - eBioMedicine Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer - eBioMedicine](https://www.thelancet.com/cms/attachment/1e65e91f-beee-4787-b481-beb258210ff6/gr1_lrg.jpg)
Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer - eBioMedicine
![Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data | British Journal of Cancer Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-018-0230-7/MediaObjects/41416_2018_230_Fig1_HTML.png)
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data | British Journal of Cancer
![3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive 3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive](https://www.snfge.org/sites/www.snfge.org/files/SNFGE/TNCD/tncd_chap-03_figure-2_0.jpg)